Adaptive Biotechnologies

Adaptive Biotechnologies is a pioneering company in the field of immune-driven medicine, specializing in the development of technologies to decode the adaptive immune system. They generate revenue through their immunosequencing platform, which is utilized in clinical diagnostics, drug discovery, and research applications. Founded in 2009, the company has made significant strides, including a notable partnership with Microsoft to map the human immune system and the development of the T-Detect COVID test. Understanding their innovative approach and key collaborations is essential for any candidate.

Recent Posts by Adaptive Biotechnologies

1-20 of 86